Day: November 12, 2020

eFFECTOR Announces Dosing of First Breast Cancer Patient with Tomivosertib in Combination with Chemotherapy Through a Grant from Stand Up To Cancer® (SU2C) Canada

SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulation...

Clinical Evidence Shows that the FlareHawk® Multiplanar Expandable Cage Delivers Favorable Fusion and Patient Outcomes Demonstrating Conformity to Endplate Anatomy with No Observed Device Subsidence

IJSS-published peer-reviewed studies demonstrate the device’s respect for neural anatomy and conformability to bony endplates through Adaptive Geometry™ PALM BEACH...

error: Content is protected !!